| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 258 | 2021 |
| Ultrafiltration rate and mortality in maintenance hemodialysis patients MM Assimon, JB Wenger, L Wang, JE Flythe American Journal of Kidney Diseases 68 (6), 911-922, 2016 | 160 | 2016 |
| Intradialytic blood pressure abnormalities: the highs, the lows and all that lies between MM Assimon, JE Flythe American journal of nephrology 42 (5), 337-350, 2016 | 109 | 2016 |
| Medication-related problems in CKD KE Cardone, S Bacchus, MM Assimon, AB Pai, HJ Manley Advances in chronic kidney disease 17 (5), 404-412, 2010 | 107 | 2010 |
| Definitions of intradialytic hypotension MM Assimon, JE Flythe Seminars in dialysis 30 (6), 464-472, 2017 | 93 | 2017 |
| Comparative cardiac safety of selective serotonin reuptake inhibitors among individuals receiving maintenance hemodialysis MM Assimon, MA Brookhart, JE Flythe Journal of the American Society of Nephrology 30 (4), 611-623, 2019 | 57 | 2019 |
| A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis MM Assimon, MA Brookhart, JP Fine, G Heiss, JB Layton, JE Flythe American Journal of Kidney Diseases 72 (3), 337-348, 2018 | 50 | 2018 |
| Intradialytic hypertension frequency and short-term clinical outcomes among individuals receiving maintenance hemodialysis MM Assimon, L Wang, JE Flythe American Journal of Hypertension 31 (3), 329-339, 2018 | 43 | 2018 |
| Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base MM Assimon, JE Flythe Current opinion in nephrology and hypertension 24 (6), 525-530, 2015 | 40 | 2015 |
| Ultrafiltration rates and the quality incentive program: proposed measure definitions and their potential dialysis facility implications JE Flythe, MM Assimon, JB Wenger, L Wang Clinical Journal of the American Society of Nephrology 11 (8), 1422-1433, 2016 | 31 | 2016 |
| Cumulative exposure to frequent intradialytic hypotension associates with new-onset dementia among elderly hemodialysis patients MM Assimon, L Wang, JE Flythe Kidney International Reports 4 (4), 603-606, 2019 | 30 | 2019 |
| Target weight achievement and ultrafiltration rate thresholds: potential patient implications JE Flythe, MM Assimon, RA Overman BMC nephrology 18, 1-13, 2017 | 28 | 2017 |
| Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit? MM Assimon, PV Salenger, HAN EL‐FAWAL, DL Mason Nephrology 17 (3), 237-242, 2012 | 26 | 2012 |
| Failed target weight achievement associates with short-term hospital encounters among individuals receiving maintenance hemodialysis MM Assimon, L Wang, JE Flythe Journal of the American Society of Nephrology 29 (8), 2178-2188, 2018 | 23 | 2018 |
| Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study MM Assimon, T Nguyen, SL Katsanos, SM Brunelli, JE Flythe BMC nephrology 17, 1-11, 2016 | 22 | 2016 |
| Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis MM Assimon, PH Pun, SM Al-Khatib, MA Brookhart, DJ Weber, ... JAMA cardiology 7 (1), 75-83, 2022 | 17 | 2022 |
| Observation stays in administrative claims databases: underestimation of hospitalized cases RA Overman, JK Freburger, MM Assimon, X Li, MA Brookhart Pharmacoepidemiology and drug safety 23 (9), 902-910, 2014 | 17 | 2014 |
| Confounding in observational studies evaluating the safety and effectiveness of medical treatments MM Assimon Kidney360 2 (7), 1156-1159, 2021 | 12 | 2021 |
| Proton pump inhibitors may enhance the risk of citalopram‐and escitalopram‐associated sudden cardiac death among patients receiving hemodialysis MM Assimon, PH Pun, SM Al‐Khatib, MA Brookhart, BN Gaynes, ... Pharmacoepidemiology and Drug Safety 31 (6), 670-679, 2022 | 11 | 2022 |
| Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End‐Stage Kidney Disease MM Assimon, L Wang, PH Pun, WC Winkelmayer, JE Flythe Journal of the American Heart Association 9 (13), e015969, 2020 | 11 | 2020 |
